HEMAGEN DIAGNOSTICS (HMGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEMAGEN DIAGNOSTICS (HMGN)

HMGN 0.0150

+14,901.5%

Aug 12 10:48 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: GARY P GROBBEL who wrote (74)	6/29/1999 10:29:00 AM
From: Yo Yo	Read Replies (2) of 98

I also follow ABAX, they are #2, I think, in the vet market. I forget the name of the big guys (can someone post it). I beleive the HMGN unit competes pretty well in human market, but that market is tougher to operate in (more regulation). From what I understand the HMGN unit has not changed much in years and needs a major overhaul to implement new technologies. However, the HMGN disks are far more profitably produced than those at ABAX. So HMGN has some decisions to make..... Milk the existing unit and let profits look good. Or get the thing up to date and let profits look week for a little while. Either way, the vet market is getting crowded. Yo Yo

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next